![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgWU0X42kci5ZYd02P59mlkdYpwlQYDn90byvQDd9Izss0_Mmwa04zKC_PLGzyD1J6egtwsE6flgyQ6SGorfYhe2Q2ROONClN5yIizDe9PjQ685itqttuxBdyh3V6uAQWiNbZUfZn0fSTj-/s320/Cardiac+Surgery+in+the+Adult,+3rd+Edition.gif)
Probably the most stimulating advance in the treatment of congenital heart disease occurred in 1944, when Alfred Blalock and Helen Taussig introduced their technique of systemic-to-pulmonary artery shunting for tetralogy of Fallot. The success of the “blue-baby” operation was so dramatic and promising that cardiac surgery began to grow at a frenzied pace. The early operative procedures for congenital anomalies, including the blue-baby operation, proved that the circulatory system could be altered to improve blood flow and cardiopulmonary function.
Download Link